Trials of anti-tuberculosis treatment as a diagnostic tool in smear-negative tuberculosis are of questionable benefit [Counterpoint]

Authors: Bernard Fourie; Karin Weyer

Source: The International Journal of Tuberculosis and Lung Disease, Volume 4, Number 11, November 2000 , pp. 997-997(1)

Publisher: International Union Against Tuberculosis and Lung Disease

Document Type: Miscellaneous

Affiliations: 1: Medical Research Council, Pretoria, South Africa

Publication date: 2000-11-01

• The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

  Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

• Editorial Board
• Information for Authors
• Subscribe to this Title
• ingentaconnect is not responsible for the content or availability of external websites

• In this: publication
• By this: publisher
• In this Subject: Internal Medicine
• By this author: Bernard Fourie ;  Karin Weyer

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers